Dongwha Pharm.Co.,Ltd announces an Equity Buyback for 100,000 shares.
July 20, 2017 at 01:46 am EDT
Share
Dongwha Pharm.Co.,Ltd (KOSE:A000020) announces a share repurchase program. Under the program, the company will repurchase up to 100,000 shares. The purpose of the program is to improve shareholder value through stock price stabilization and employee stock ownership association contribution. The program will expire on October 20, 2017. As of July 19, 2017, the company had 266,500 shares in treasury within scope available for dividend and had 240 shares in treasury under other capacities.
DONGWHA PHARM.CO., LTD is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products consist of ethical drugs, including digestive system remedies, antibiotics, cardiovascular and metabolic disease treatments, non steroidal anti-inflammatory drugs, respiratory remedies, muscle relaxants, nervous system remedies, dermatological remedies and urinary system remedies, and over-the-counter (OTC) drugs, including cold remedies, dental remedies, dermatological remedies, hepatic protectors, nutrients, tonics, topical analgesics, anti-smoking agents and others. It also provides medicine raw materials, health food and drinks, as well as cosmetics. The Company distributes its products within domestic market and to overseas markets.
DONGWHA PHARM.CO.,LTD 
